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Background. Hepatitis E virus (HEV) causes acute onset of jaundice and a high case-fatality ratio in pregnant
women. We provide a clinical description of hospitalized case patients and assess the speciﬁc impact on pregnant
women during a large epidemic of HEV infection in a displaced population in Mornay camp (78,800 inhabitants),
western Darfur, Sudan.
Methods. We reviewed hospital records. A sample of 20 clinical cases underwent laboratory conﬁrmation.
These patients were tested for immunoglobulin G (IgG) and immunoglobulin M (IgM) antibody to HEV (serum)
and for ampliﬁcation of the HEV genome (serum and stool). We performed a cross-sectional survey in the
community to determine the attack rate and case-fatality ratio in pregnant women.
Results. Over 6 months, 253 HEV cases were recorded at the hospital, of which 61 (24.1%) were in pregnant
women. A total of 72 cases (39.1% of those for whom clinical records were available) had a diagnosis of hepatic
encephalopathy. Of the 45 who died (case-fatality ratio, 17.8%), 19 were pregnant women (speciﬁc case-fatality
ratio, 31.1%). Acute hepatitis E was conﬁrmed in 95% (19/20) of cases sampled; 18 case-patients were positive
for IgG (optical density ratio 3), for IgM (optical density ratio 12 ), or for both, whereas 1 was negative for
IgG and IgM but positive for HEV RNA in serum. The survey identiﬁed 220 jaundiced women among the 1133
pregnant women recorded over 3 months (attack rate, 19.4%). A total of 18 deaths were recorded among these
jaundiced pregnant women (speciﬁc case-fatality ratio, 8.2%).
Conclusions. This large epidemic of HEV infection illustrates the dramatic impact of this disease on pregnant
women. Timely interventions and a vaccine are urgently needed to prevent mortality in this special group.
Hepatitis E virus (HEV), a nonenveloped, positive-
sense, single-stranded RNA virus, is recognized as the
principal cause of enterically transmitted non-A, non-
B hepatitis, which occurs worldwide although rarely in
industrialized countries [1]. Evidence for the existence
of a new epidemiologically distinct virus has beenavail-
able since the early 1980s, butthevirushasonlyrecently
been identiﬁed [2].
Infections due to hepatitis A virus and HEV are very
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similar. They are clinically characterized by an icteric
phase, with discoloration of sclerae, jaundice, and oc-
casionally dark urine. They are both self-limited, with
a low mortality rate in the general population [3, 4].
However, probably the most strikingdifferencebetween
the infections is the high mortality seen among preg-
nant women with HEV infection, especially those in
the third trimester. Case-fatality ratios range from 10%
to 42% [5–9].
HEV is transmitted via the fecal-oral route andrarely
through person-to-person transmission. HEV is rec-
ognized as a common source of waterborne outbreaks,
involving fecally contaminated water [3]. The ﬁrst doc-
umented hepatitis E outbreak occurred in Delhi, India,
in 1955–1956 [1]. Additional outbreaks have been re-
ported among civilians [10–15] and military popula-1680 • CID 2006:42 (15 June) • Boccia et al.
tions [16–20]. To our knowledge, only 2 episodes have been
reported among refugees [4, 21].
In June 2004, a large hepatitis E outbreakoccurredinwestern
Darfur, Sudan. A total of 2621 cases were reported between 26
June and 31 December 2004 in Mornay Internally Displaced
Persons Camp (78,800 inhabitants). The medical nongovern-
mental organization Me ´decins Sans Frontie `res was the main
health care provider in the camp, with a hospital and 2 out-
patient departments. The epidemiological investigation sug-
gested an increased risk of HEV infection with drinking water
from chlorinated sources [22].
The rationale of this investigation was to collect clinical in-
formation on cases of hepatitis E during an outbreak in a large
camp, which has rarely been reported. Speciﬁcally, we aimed to
have a more accurate picture of its impact on pregnant women
to provide recommendations for interventions in the future.
METHODS
Description of hospitalized case patients. A clinical case def-
inition was made after the ﬁrst cases of acute hepatitis E were
conﬁrmed on serum specimens at the Naval Medical Research
Unit in Cairo, Egypt. Surveillance data in Darfur did not report
other diagnoses as important causes of acute jaundice. There-
fore, a case of hepatitis E was deﬁned as occurring in a person
resident or displaced in Mornay who developed an acute onset
of jaundice since 1 July 2004 (deﬁned as a yellow coloration
of the sclera). Patients with a positive result of malaria rapid
diagnostic test were excluded. Hepaticencephalopathywasclas-
siﬁed as either mild (presence of confusion or agitation in
addition to jaundice) or severe (presence of coma or convul-
sions in addition to jaundice). Diagnosis was made by the
medical doctor responsible on the ward of admission on the
basis of the clinical presentation of patients.
During the presence of the investigation team in the ﬁeld, a
sample of inpatients underwent laboratory conﬁrmation with
serological analysis and detection of HEV RNA in serum sam-
ples and stool specimens [22]. Acute HEV infectionwasdeﬁned
as an optical density (OD) ratio of 3 for HEV IgG, an OD
ratio of 12 for HEV IgM, and/or presence of HEV RNA in
stool or serum [22].
Demographic and clinical information was extracted from
medical records of hospitalized casepatientswithhepatitisfrom
1 July until 31 October 2004. Data were recorded on a standard
form; entered into EpiData software, version 3.0 (EpiData As-
sociation); and analyzed on EpiInfo software, version 6.04
(Centers for Disease Control and Prevention). The case-fatality
ratio among inpatients was calculated using the total number
of jaundiced patients admitted at the hospital during the study
period as the denominator.
Cross-sectionalsurveyofpregnantwomen. Thestudypop-
ulation consisted of all women resident or displaced in Mornay
Camp and pregnant between 1 July and 30 September 2004.
This included women pregnant at the time of the survey and
women who had given birth in the past 3 months. The study
population also includedpregnantwomenwhohaddiedduring
the study period. The survey was done by 13 teams of 2 in-
terviewers, 1 team per camp administrative district (limits de-
ﬁned by the camp authorities). Each team was trained to rec-
ognize jaundiced persons, and a pilot phase was conducted to
ensure compliance with standard procedures and deﬁnitions.
Data were gathered directly from women or from the nearest
relative in case of absence or death of the woman. Information
collected included pregnancy status, based on answers given by
the interviewee; presence of acute jaundice, deﬁned as yellow
coloration of the sclera, either observed by the interviewer or
as reported by the interviewee in the study period; and occur-
rence of death reported by relatives. All pregnant women en-
countered during the survey were encouraged to seek medical
attention even if only mild symptoms had occurred. Attack
rates by districts were calculated.
RESULTS
Hospital investigation. The ﬁrst 2 cases were diagnosed on 7
and 8 July 2004. Both were in pregnant women, who had been
admitted to the hospital in coma, who died within 48 h. After
this, the number of admitted patients increased each week,peak-
ing during weeks 33–34 and decreasing afterwards (ﬁgure 1).
A total of 253 case patients with hepatitis E were admitted
to the hospital until December 31. These admissions accounted
for 15.3% of all hospital admissions during this period and
ranged between 8% of admissions in July (21 of 248) and 27%
in August and November (93 of 343 and 26 of 94, respectively).
Twenty serum and 13 stool samples were collected from 20
hospitalized case patients. The diagnosis of acute hepatitis E
was conﬁrmed in 19 (95%). Among these 19 with conﬁrmed
cases, 18 were positive for IgG (OD ratio, 3), IgM (OD ratio,
12 ), or both, and 1 was negative for IgG and IgM but had
HEV RNA detected in serum. Among the18whotestedpositive
for IgG and IgM, 4 also had HEV RNA present in stoolsamples,
and 3 had HEV RNA present in serum and stool samples.
Demographic and clinical characteristics were obtainedfrom
184 case patients (73%). The majority were adult women (129
[70.1%]), and 143 (77.7%) were aged 15–44 years. Hepatic
encephalopathy was recorded in 72 cases (39.1%); it was mild
in 35 cases and severe in 37. The median delaybeforeadmission
was 5 days (range, 1–25 days) (data available for 154 case
patients). Duration of hospitalization was available for 180 case
patients, accounting for a median duration of stay of 4 days
(range, 1–16 days) (table 1). The most frequent symptoms atHigh Mortality Associated with HEV Outbreak • CID 2006:42 (15 June) • 1681
Figure 1. Number of case patients who were hospitalized ( ) because of jaundice and number who died ( ), by week of admission n p 253 n p 45
to Me ´decins Sans Frontie `res Hospital, Mornay Camp, western Darfur, Sudan, July–December 2004.
presentation were jaundice (98%), fever (65%), vomiting (59%),
abdominal pain (50%), and anorexia (42%).
Between July and December, 45 case patients with hepatitis
E died (case-fatality ratio, 17.8%). Demographic and clinical
information were available for 31 of those patients who died:
26 (83.9%) were aged 15–44 years, and 22 (71%) were female.
All 31 patients presented with mild or severe hepatic enceph-
alopathy. The median duration of symptoms before admission
was 3 days (range, 2–19 days), and the median duration of
hospitalization was 2 days (range, 1–7 days) (data available for
26 and 31 cases, respectively) (table 1). Of the 45 case patients
who died, 19 (42.2%) were pregnant women, yielding a speciﬁc
case-fatality ratio in this group of 31.1% (19 of 61 women).
The monthly case-fatality ratio for the 6-month period is re-
ported in table 2.
Cross-sectional survey. Overall, 1133 pregnant women
were identiﬁed during the 2-day survey, representing 1.4% of
the Mornay population. Among them, 220 episodes of acute
jaundice were recorded during the study period (attack rate,
19.4%). The attack rate among pregnant women ranged be-
tween 10.5% ( ) in Salam 0 district and 33.6% ( ) n p 4 n p 41
in Salam 2 district (table 3). Of 220 pregnant case patients, 18
(8.2%) died (table 3). One-half of the deaths were reported
from Shamal 2 district. During the study period, 169 (77%)
pregnant women with jaundice had attended a health facility
for a medical consultation.
DISCUSSION
To our knowledge, this is the largest outbreak of hepatitis E
documented in the literature among internal displaced persons
or refugees, illustrating the dramatic impact of this disease on
pregnant women at the community level. Between July and
December 2004, 2621 cases of hepatitis E were recorded in
Mornay camp, accounting for 3% of the camp population[22].
The burden represented by this outbreak is reﬂected by the
proportional morbidity from hepatitis E at the hospital: case
patients with hepatitis E occupied, on average, 1 in 7 beds
between July and December 2004 and 1 in 4 beds in August
at the peak of the outbreak. During that month, on average, 1
patient was admitted each day to the intensive care unit with
a diagnosis of hepatic encephalopathy. These ﬁgures show the
impact of this disease at the hospital level; personnel wereover-
whelmed with the number of hepatitis E cases and were unable
to attend to other patients.
Women represented a large proportion of hospitalized pa-1682 • CID 2006:42 (15 June) • Boccia et al.
Table 1. Demographic and clinical characteristics of patients
hospitalized with jaundice and case patients who died, Mornay
Camp, western Darfur, Sudan, July–October 2004.
Characteristic
All hospitalized
case patients
Case patients
who died
Age, years
!5 3 (1.6) 0 (0)
5–14 21 (11.4) 2 (6.5)
15–44 143 (77.7) 26 (83.9)
145 14 (7.6) 2 (6.5)
Unknown 3 (1.6) 1 (3.2)
Total 184 (100.0) 31 (100.0)
Sex
Male 54 (29.3) 8 (25.8)
Female 129 (70.1) 22 (71.0)
Unknown 1 (0.5) 1 (3.2)
Total 184 (100.0) 31 (100.0)
Delay before admission, median
days (range) 5 (1–25) 3 (2–19)
Duration of hospital admission,
median days (range) 4 (1–16) 2 (1–7)
Final diagnosis
Simple hepatitis 112 (60.9) 0 (0.0)
Mild hepatic encephalopathy 35 (19.0) 9 (29.0)
Severe hepatic encephalopathy 37 (20.1) 22 (71.0)
Total 184 (100.0) 31 (100.0)
Outcome
Died 31 (16.8) 31 (100.0)
Discharged 149 (81.0) …
Unknown 4 (2.2) …
Total 184 (100) 31 (100.0)
NOTE. Data are no. (%) of patients, unless otherwise indicated.
Table 2. Monthly case-fatality ratio among overall hospitalized pa-
tients ( ) and pregnant women admitted to hospital ( ), n p 253 n p 61
Mornay Camp, western Darfur, Sudan, July–December 2004.
Month
Proportion of deaths
among hospitalized
case patients per
month (%)
a
Proportion of deaths
among pregnant
women admitted to
the hospital (%)
July 5/21 (23.8) 4/6 (66.7)
August 15/93 (16.1) 6/15 (40.0)
September 7/47 (14.9) 2/12 (16.7)
October 9/50 (18.0) 1/11 (9.1)
November 8/26 (30.8) 5/10 (50.0)
December 1/16 (6.3) 1/7 (14.3)
a These deaths represented, respectively, 5 (14%) of 36, 15 (43%) of 35,
7 (23%) of 30, 9 (38%) of 24, 8 (42%) of 19, and 1 (20%) of 5 total monthly
hospital deaths between July and December 2004.
tients, although among patients with hepatitis E, male patients
traditionally predominate over female patients at a ratio of 1.5–
3.5:1 [23]. Sex distribution might be attributed to a more severe
clinical presentation in women, especially those who are preg-
nant, and/or could reﬂect the unbalanced sex distribution of the
populationofDarfur,causedbytheviolenteventsoccurringsince
December 2003 and well documented by several surveys [24].
Another unexpected feature of this outbreak was the observed
case fatality. Clinical symptoms reported were those typical of
hepatitis E, whereas case fatality observed in the hospitalized
patients (18%) is higher than reported elsewhere(0%–5.7%)[12,
14, 15, 19, 21]. This result might be explained by the fact that
the outbreak at Mornay affected people with impaired health
status because of poor living conditions, extremely unsafe san-
itary conditions, and poor access to food. Security concerns and
lack of conﬁdence in Western medicine might also have delayed
seeking access to the healthcare facility.Inaddition,theextremely
difﬁcult working conditions (e.g., lack of proper health care in-
frastructure and insufﬁcient staff members to ensure anadequate
turnover in the hospital), made the treatment and care of these
patients particularly difﬁcult and not as effective as it could have
been in a more stable setting. All of these aspects may have
increased the vulnerability of the population to the severe form
of this disease or even worsened the clinical presentation and
outcome of patients admitted to hospital.
Almost one-quarter of the patients with hepatitis E admitted
to the hospital were pregnant women, and among these, one-
third died. In Mornay, the case-fatality ratio among pregnant
women admitted to the hospital was almost twice that of other
hospitalized patients with HEV infection (42% vs. 18%). This
high case-fatality ratio among pregnant women, although still
unexplained, is well documented in other studies and was ex-
pected in our case series [1, 3, 23, 25].
The cross-sectional survey of pregnant women showed not
only a higher case-fatality ratio among pregnant women than
among others (31% vs. 18%) but also a higher attack rate than
in the camp population (19.4% vs. 3.3%) [22]. However, com-
parisons must be interpreted with caution, because data were
not collected by the same means [22]. In addition, it was not
possible to conﬁrm the information gathered, and quality of
data is entirely dependent on the respondents’ reliability. We
could not identify particular risk factors explaining higher at-
tack rates in certain districts than in others. Water supplies in
all districts were a mixture of deep-drilled water supply, mod-
erately deep water supply, chlorinated water, and water taken
directly from the river.
Whether the higher attack rate and case-fatality ratio among
pregnant women are the result of a higher risk of developing
symptomatic disease or of an actual increased susceptibility to
the infection remains unclear [26, 27]. Some authors suggest
that pregnant women are at higher a risk for developing severe
acute hepatitis and even fulminant hepatic failure than are the
general population, implying that even mild infection during
pregnancy might contribute to a rapid progression of infectionHigh Mortality Associated with HEV Outbreak • CID 2006:42 (15 June) • 1683
Table 3. Geographic distribution of cases of acute jaundice per camp district, num-
ber of deaths, and case-fatality ratio among pregnant women, Mornay Camp, western
Darfur, Sudan, July–September 2004.
District Population
No. of
pregnant
women
No. of
patients with
jaundice
No. of
deaths
Attack
rate, %
Case-fatality
rate, %
Salam 0 7383 38 4 1 10.5 25.0
Salam 1 5803 107 16 3 15.0 18.8
Salam 2 7966 122 41 0 33.6 0.0
Salam 3 2558 56 7 0 12.5 0.0
Jebel 1 6822 124 34 1 27.4 2.9
Jebel 2 2886 55 9 0 16.4 0.0
Wadi B 9792 121 14 1 11.6 7.1
Wadi A1 7972 126 18 0 14.3 0.0
Wadi A2 4061 64 18 0 28.1 0.0
Sherig 1 4618 58 7 0 12.1 0.0
Sherig 2 8232 72 13 0 18.1 0.0
Shamal 1 2512 25 3 3 12.0 100.0
Shamal 2 8226 165 36 9 21.8 25.0
Total 78,831 1133 220 18 19.4 8.2
and a higher rate of spontaneous abortion and intrauterine
death [10, 28].
Although it was impossible to follow-up these complications
associated with HEV infection in hospitalizedpregnantwomen,
data in the literature suggest that they may have been severe.
In a recent prospective study of 62 pregnant women who had
jaundice in the third trimester, HEV accounted for 37% of
cases of acute viral hepatitis and 81% of cases of fulminant
hepatic failure [29]. More than one-quarter of women with
HEV infection had obstetric complications, including prema-
ture rupture of membrane, intrauterine growth restriction,pla-
centa previa, and retained placenta. Approximately two-thirds
of women with HEV infection had preterm deliveries [29], and
in an outbreak in Pakistan, 4 of 8 fatalities occurred among
infants born to HEV-infected mothers [10].
Another indirect effect of this outbreak that we did notassess
is the number of orphans the outbreak may have caused. Even
without quantitative estimates, we can expect this number to
be signiﬁcant because of the high number of children per
woman in this setting [24] and the observed high mortality
observed among women of childbearing age. Consequences of
orphanhood are always severe but can be even more dramatic
in an unsafe and unstable context such as western Darfur.
The impact of this outbreak points to the importance of an
HEV vaccine as a potential preventive measure. At present, no
vaccine is available, although a recombinant vaccine has just
undergone clinical trials in Nepal [30]. Some authors have
questioned the public health impact of this vaccine compared
with improvements in water sanitation and water supply in
countries of endemicity [31]. We believe that the prompt use
of a vaccine in a context such as Mornay, especially targeting
pregnant women, would have dramatically decreased the num-
ber of deaths. More research into the development of an ef-
fective vaccine is therefore needed. Speciﬁc interventions tar-
geting pregnant women concerning water supply, hygiene, and
education should also be evaluated. Today, hepatitis E is con-
sidered an emerging disease of global importance, but much
of our understanding of this disease is still based on outbreak
investigations and clinical observations. Aside from the devel-
opment of a protective vaccine, there is also an urgent need
for population-based studies aimed at addressing major epi-
demiological issues, such as the apparent increased morbidity
and mortality in pregnant women, the higher clinical attack
rate among adults in outbreaks, the predominance of male
patients among clinical case patients, and the importance of
animals as a reservoir for HEV. We hope that these studies will
prompt detailed investigations of future episodes and possibly
their prevention.
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